IP Library › Assignment 059690/0237
Patent Assignment
Reel/Frame 059690/0237

Declaration of Brenda Herschbach Jarrell

Recorded: 2022-04-12 Pages: 4
Assignors
DEUTSCHES KREBSFORSCHUNGSZENTRUM
Executed: 2022-04-12
Assignees
RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
GRABENGASSE 1, HEIDELBERG, 69117, GERMANY
DEUTSCHES KREBSFORSCHUNGSZENTRUM
IM NEUENHEIMER FELD 280, HEIDELBERG, 69120, GERMANY
Covered Property (1)
Labeled Inhibitors of Prostate Specific Membrane Antigen (Psma) as Agents for the Treatment of Prostate Cancer
Application: 17/110,558 →
Publication: US 2021/0177996
Related Assignments (5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 3, 2020
From: EDER, MATTHIAS; KOPKA, KLAUS; SCHÄFER, MARTIN; BAUDER-WÜST, ULRIKE
To: DEUTSCHES KREBSFORSCHUNGSZENTRUM
Reel/Frame 054530/0239 →
Assignment of Assignor's Interest Dec 3, 2020
From: HABERKORN, UWE; MIER, WALTER
To: RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
Reel/Frame 054530/0342 →
Confirmation of Ownership (as Filing Relates to Compounds That Are "Derivatives") Feb 9, 2021
From: UNIVERSITY OF HEIDELBERG
To: UNIVERSITY OF HEIDELBERG; MOLECULAR INSIGHT PHARMACEUTICALS, INC.
Reel/Frame 055266/0204 →
Nunc Pro Tunc Assignment Jun 30, 2023
From: DEUTSCHES KREBSFORSCHUNGSZENTRUM; RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
To: NOVARTIS PHARMA AG
Reel/Frame 064132/0202 →
Assignment of Assignor's Interest Jun 30, 2023
From: NOVARTIS PHARMA AG
To: NOVARTIS AG
Reel/Frame 064132/0352 →